Zynerba sinks twice as cannabis trials flop; strike three looms, so where’s the Ouija board?

The News: Zynerba Pharmaceuticals Inc. (ZYNE) lost more than half its value last week to $7.03 after the drug developer said its synthetic cannabis-based gel for epilepsy failed a mid-stage… Read more »



Kite submits IND for CAR-T multiple myeloma treatment; Novartis keeping wary eye on rival’s latest move in high-stakes race.

The News: Kite Pharma Inc. (Santa Monica CA) said it has submitted to the FDA an Investigational New Drug (IND) application to launch a Phase 1, first-in-human trial of a… Read more »



East Coast reigns supreme in Best Hospitals rankings; what purpose does it really serve?

The News: For the second consecutive year, the Mayo Clinic in Rochester, MN, claimed the number one spot in the annual honor roll of best hospitals published by US News and… Read more »



Endo coming out of the darkness into the light; contrarians, buy this name.

The News: Endo International Plc (Dublin IRL) on Tuesday (August 8, 2017) lowered its full-year revenue forecast, saying it expected lower sales of branded drugs to add to the pricing… Read more »



Teva stock crashes on 2Q earnings disaster; run for the hills, or buy at fire sale price?

The News: Teva Pharmaceutical Industries Ltd., which has been without a permanent CEO for six months, plunged $11.74, or 36% last week, to $20.60–the most in almost two decades. The… Read more »



Centrists design bipartisan healthcare stabilization plan; reps throw down gauntlet on turf battle with White House.

A coalition of roughly 40 House Republicans and Democrats unveiled a slate of Obamacare fixes last week they hope will gain traction after the Senate’s effort to repeal the law… Read more »



Breakthrough gene editing reported that removes deadly embryonic mutations; biotech licks its chops as stakes are incalculable for ensuing blockbusters.

The News: Scientists have modified human embryos to remove genetic mutations that cause heart failure in otherwise healthy young people in a landmark demonstration of the controversial procedure, The Guardian… Read more »



Americans are sicker, die younger while spending the most on health care; what South Korea can teach us.

The News: Typically, the more a developed country spends on health care, the longer its people live. The US, which spends the most on health care, defies that tendency another… Read more »



Biogen’s poster presentation for Alzheimer’s candidate hardly noticed at London AAIC meeting as market focuses on quarterly results instead; start accumulating.

Biogen Inc. (Cambridge MA) laid out long-term plans to strengthen its core multiple sclerosis (MS) business, develop more neuroscience drugs and shop for late-stage assets, after reporting robust second-quarter results,… Read more »



UnitedHealthcare 2nd quarter sparkles; but time to figure out how Centene, Molina exploit Medicaid?

The News: UnitedHealth Group Inc.’s (Minnetonka MN) second-quarter earnings jumped 11% to beat analysts’ expectations even though the nation’s largest health insurer took a bigger hit than expected from coverage… Read more »